Related Experiment Video
Updated: Feb 10, 2026

08:06
Robotic Cochlear Implantation for Direct Cochlear Access
Published on: June 16, 2022
4.1K
Periosteal Flap in Cochlear Implantation, How I Do It?
Yasser Ahmed Fouad1, Thomas Roland2
1Department of Otorhinolaryngology, Zagazig University School of Medicine, Zagazig, Egypt.
The Journal of International Advanced Otology
|May 17, 2018
Summary
A new periosteal flap technique for cochlear implantation surgery proved safe and effective in 26 patients. The novel design prevented complications and ensured the mastoid emissary vein remained intact.
Area of Science:
- Otolaryngology
- Neurosurgery
- Surgical Innovation
Background:
- Cochlear implantation requires precise surgical techniques.
- Periosteal flap design is crucial for device stability and wound healing.
- Potential complications include bleeding from the mastoid emissary vein.
Purpose of the Study:
- To describe and evaluate a novel anterior-based periosteal flap design for cochlear implantation.
- To assess the safety and efficacy of this modified flap in preventing complications.
Main Methods:
- A modified anterior-based periosteal flap was designed and applied.
- The technique was used in 26 patients undergoing cochlear implantation.
- Surgical outcomes and complications were monitored.
Main Results:
- No intraoperative or postoperative complications were observed.
- No instances of device migration, infection, hematoma, or delayed healing occurred.
- The mastoid emissary vein remained intact in all patients.
Conclusions:
- The modified anterior-based periosteal flap is a safe and effective technique.
- This flap design successfully avoids mastoid emissary vein bleeding.
- It facilitates complete periosteal repositioning over the cochlear implant.
Related Concept Videos
Long-patch Base Excision Repair
8.0K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
8.0K
Convergent Evolution
33.1K
Evolution shapes the features of organisms over time, ensuring that they are suited for the environments in which they live. Sometimes, selection pressure leads to the rise of similar but unrelated adaptations in organisms with no recent common ancestors, a process known as convergent evolution.
33.1K
Cleavage and Blastulation
50.4K
After a large-single-celled zygote is produced via fertilization, the process of cleavage occurs while zygotes travel through the uterine tube. Cleavage is a mitotic cell division that does not result in growth. With each round of successive cell division, daughter cells get increasingly smaller.
50.4K
Reproductive Cloning
32.8K
Reproductive cloning is the process of producing a genetically identical copy—a clone—of an entire organism. While clones can be produced by splitting an early embryo—similar to what happens naturally with identical twins—cloning of adult animals is usually done by a process called somatic cell nuclear transfer (SCNT).
Somatic Cell Nuclear Transfer
In SCNT, an egg cell is taken from an animal and its nucleus is removed, creating an enucleated egg. Then a somatic...
Somatic Cell Nuclear Transfer
In SCNT, an egg cell is taken from an animal and its nucleus is removed, creating an enucleated egg. Then a somatic...
32.8K
Bacterial Signaling
41.2K
Bacterial signaling can occur within bacteria (intracellular) or between bacteria (intercellular). At times, a group of bacteria behaves like a community. To achieve this, they engage in quorum sensing, the perception of higher cell density that causes changes in gene expression. Quorum sensing involves both extracellular and intracellular signaling. The signaling cascade starts with a molecule called an autoinducer (AI). Individual bacteria produce AIs that move out of the bacterial cell...
41.2K
In-vitro Mutagenesis
16.5K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
16.5K

